Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parijat Bhatnagar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advanced Biosystems|May 12, 2020
Lentivirus Manufacturing Process for Primary T-Cell Biofactory ProductionHarikrishnan Radhakrishnan, Harold S Javitz, Parijat Bhatnagar
Biomedical Microdevices|February 9, 2008
Protein functionalized micro hydrogel features for cell-surface interactionParijat Bhatnagar, Alan J Nixon, Il Kim, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 4, 2010
Multiplexed protein patterns on a photosensitive hydrophilic polymer matrixParijat Bhatnagar, George G Malliaras, Il Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 16, 2025
Syngeneic CAR T cells engineered for persistent delivery of desired proteinsSherri L Newmyer, Harikrishnan Radhakrishnan, Harold S Javitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2024
Engineered CD4 T cells for in vivo delivery of therapeutic proteinsHarikrishnan Radhakrishnan, Sherri L Newmyer, Harold S Javitz, et al.
Bioengineering & Translational Medicine|March 17, 2023
Electrically regulated cell-based intervention for viral infectionsSherri Newmyer, Marvin A Ssemadaali, Harikrishnan Radhakrishnan, et al.
Advanced Biosystems|April 16, 2019
Modular Antigen-Specific T-cell Biofactories for Calibrated In Vivo Synthesis of Engineered ProteinsClaire E Repellin, Puja Patel, Lucia Beviglia, et al.
Advanced Biology|April 19, 2021
NK-Cell Biofactory as an Off-the-Shelf Cell-based Vector for Targeted In Situ Synthesis of Engineered ProteinsClaire E Repellin, Marvin A Ssemadaali, Sherri Newmyer, et al.
Microbiology Spectrum|July 19, 2022
Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 InfectionMarvin A Ssemadaali, Sherri Newmyer, Harikrishnan Radhakrishnan, et al.
Molecular Medicine (Cambridge, Mass.)|March 28, 2026
CD4 T-cell platform for delivering interferons as an antiviral countermeasure with a focus on SARS-CoV-2Xiaohe Liu, Marvin A Ssemadaali, Harikrishnan Radhakrishnan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advanced Biosystems|May 12, 2020
Lentivirus Manufacturing Process for Primary T-Cell Biofactory ProductionHarikrishnan Radhakrishnan, Harold S Javitz, Parijat Bhatnagar
Biomedical Microdevices|February 9, 2008
Protein functionalized micro hydrogel features for cell-surface interactionParijat Bhatnagar, Alan J Nixon, Il Kim, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 4, 2010
Multiplexed protein patterns on a photosensitive hydrophilic polymer matrixParijat Bhatnagar, George G Malliaras, Il Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 16, 2025
Syngeneic CAR T cells engineered for persistent delivery of desired proteinsSherri L Newmyer, Harikrishnan Radhakrishnan, Harold S Javitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2024
Engineered CD4 T cells for in vivo delivery of therapeutic proteinsHarikrishnan Radhakrishnan, Sherri L Newmyer, Harold S Javitz, et al.
Bioengineering & Translational Medicine|March 17, 2023
Electrically regulated cell-based intervention for viral infectionsSherri Newmyer, Marvin A Ssemadaali, Harikrishnan Radhakrishnan, et al.
Advanced Biosystems|April 16, 2019
Modular Antigen-Specific T-cell Biofactories for Calibrated In Vivo Synthesis of Engineered ProteinsClaire E Repellin, Puja Patel, Lucia Beviglia, et al.
Advanced Biology|April 19, 2021
NK-Cell Biofactory as an Off-the-Shelf Cell-based Vector for Targeted In Situ Synthesis of Engineered ProteinsClaire E Repellin, Marvin A Ssemadaali, Sherri Newmyer, et al.
Microbiology Spectrum|July 19, 2022
Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 InfectionMarvin A Ssemadaali, Sherri Newmyer, Harikrishnan Radhakrishnan, et al.
Molecular Medicine (Cambridge, Mass.)|March 28, 2026
CD4 T-cell platform for delivering interferons as an antiviral countermeasure with a focus on SARS-CoV-2Xiaohe Liu, Marvin A Ssemadaali, Harikrishnan Radhakrishnan, et al.
Pageof 2